Zimberelimab is an anti-programmed cell death protein-1 (PD-1) monoclonal antibody being developed by Gloria Biosciences, Arcus…
Gilteritinib is a small molecule part of the FLT3 tyrosine kinase inhibitors that presented a greater…
Brand name: Ventop. Generic name: Venetoclax [Indications] Venetoclax is a bcl-2 inhibitor for the treatment of…
About Enasidenib Enasidenib is a medication used to treat relapsed or refractory acute myeloid leukemia (AML) in people with…
About Fulzerasib Fulzerasib is a novel, orally active, potent KRAS G12C inhibitor designed to effectively target the…
About Ensartinib Ensartinib is a novel, aminopyridazine-based small molecule that potently inhibits ALK. Ensartinib is 10-fold…
About Penpulimab Penpulimab is an IgG1 monoclonal antibody that's designed to eliminate Fcγ receptor binding and…
About Stiripentol Stiripentol is an anticonvulsant medication used for the treatment of Dravet syndrome - a serious genetic brain disorder.…
About Aprocitentan Aprocitentan is a once-daily, orally active, dual endothelin receptor antagonist, which inhibits the binding…
About Sparsentan Sparsentan is a medication used for the treatment of primary immunoglobulin A nephropathy.Sparsentan is an endothelin and…
About Fidaxomicin Fidaxomicin is the first member of a class of narrow spectrum macrocyclic antibiotic drugs…
About Finerenone Finerenone is a medication used to reduce the risk of kidney function decline, kidney…
About Fezolinetant Fezolinetant is a medication used for the treatment of hot flashes (vasomotor symptoms) due to menopause.It is a small-molecule, orally…
Sunvozertinib (DZD9008) is an oral, potent, irreversible, and selective EGFR TKI targeting EGFR exon20ins as well as EGFR sensitizing,…
About Ivonescimab Ivonescimab is the most advanced PD-1/VEGF bispecific antibody in clinical development in the U.S.,…
About Glumetinib or Gumarontinib Glumetinib (SCC244) also named Gumarontinib， is a highly selective, orally bioavailable, ATP-competitive c-Met…
Copyright © 2021-2022 LienTeh.net All rights reserved.
